August 13 2020

IBANDRONIC ACID

List of brands containing ibandronic acid   

This page contains a list of brands of authorized pharmaceutical specialties of the active principle ibandronic acid in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

Ibandronic acid belongs to a group of medicines called bisphosphonates. It contains no hormones.

This substance inhibits increased loss of calcium from bone (bone resorption) and returning to normal the high calcium blood levels. It also prevents bone complications and fractures related to the spread of cancer cells in bone.

This medicine is used to treat osteoporosis in patients who are at high risk for fractures. It has been shown to reduce the risk of vertebral fractures but not the risk of hip fractures. It is also indicated for treat pathologically high serum calcium levels (hypercalcemia) as a result of tumors.

It is also indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

Ibandronic acid prevents loss of bone from osteoporosis and helps to rebuild bone. Therefore, the drug reduces the chances of fracture. Healthy habits also facilitate the favorable effects of treatment. These include a balanced diet rich in calcium and vitamin D; walking or any other weight-bearing exercise; not smoking and not drinking too much alcohol.

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given ibandronic acid.

Other ingredients of available commercial presentations:

Tablets:

Each tablet contains 50 or 150 mg of ibandronic acid. The other ingredients are:

Tablet core: lactose monohydrate, povidone, microcrystalline cellulose, crospovidone, purified stearic acid and colloidal anhydrous silica.

Tablet coat:

hypromellose, titanium dioxide, talc and macrogol 6000.

Injectable solution: Each vial contains 1 mg ibandronic acid (1.12 mg monohydrate monosodium salt) per ml solution. The other ingredients are sodium chloride, acetic acid, sodium acetate, and water for injections.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Important information     

The tablets contain lactose. If your doctor has told you that you have an intolerance to sugars, contact him before taking it.

Before taking the drug     

Do not use ibandronic acid

If you are allergic (hypersensitive) to ibandronic acid or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

- If you have low levels of calcium in the blood or think you may have them.
- If you are pregnant, you think you might be pregnant, or you are breastfeeding your child.

Ibandronic acid should not be given to children or teenagers.

Take special care with ibandronic acid

Some people need special care during treatment with ibandronic acid. Consult your doctor:

- If you have any disturbance of mineral metabolism (such as vitamin D deficiency).
- If you can not stand or sit for an hour straight.
- If you have any kidney problems.

- If you have ever experienced problems with your esophagus (the tube that connects the mouth to the stomach). Esophageal problems can cause severe symptoms such as chest pain, severe pain after swallowing food or drinking, severe nausea or vomiting. If you have any of these symptoms, tell your doctor right away.

If you are being treated by the dentist or you will undergo dental surgery, tell your dentist that you are being treated with ibandronic acid.

Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.

If in doubt, consult your doctor.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription or any supplement containing calcium, magnesium, iron, or aluminum.

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) They can irritate the stomach and intestine; as bisphosphonates (including ibandronic acid). Be therefore careful if you take painkillers or anti-inflammatories while you are taking this drug. (among NSAIDs are ibuprofen, diclofenac, and naproxen).

After swallowing the daily (or monthly) ibandronic acid tablet, wait for 1 hour before taking any other medicines, including medicines tablets for indigestion, calcium supplements, and vitamins.

Use with food and beverages

Do not take Ibandronic acid with solid or liquid foods:

Ibandronic acid loses effectiveness if taken with food.

Special physiological situations

Pregnancy and lactation:

Always consult your doctor or pharmacist before taking any medicine during pregnancy or breastfeeding.

Do not take Ibandronic acid if you are pregnant or breastfeeding. If you are breastfeeding may need to stop to breastfeed your child if you take Ibandronic acid.

Driving and using machines

It is very unlikely that ibandronic acid affects your ability to drive and use machines

Consult your doctor or pharmacist before taking any medicine.

How to use ibandronic acid     

Follow carefully the instructions of use of ibandronic acid provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given on this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

150 mg tablets:

The usual dose is one tablet per month.

Choose the day of the month that will be easier to remember. You can choose the same date (either the first day of each month) or the same day (as the first Sunday of each month). Choose what best fits your routine.

50 mg tablets:

The usual dose of ibandronic acid is one tablet a day.

For the two dosage forms:

It is important that the tablet reaches the stomach quickly and cause less irritation.

Take the tablet after a minimum of 6 hours after the last meal or drink (except water) you can only drink water during this six-hour period.

Take the tablet upon waking, before eating breakfast or drink liquids (on an empty stomach).

Swallow the tablet with a glass of tap water (at least 200 ml). Do not take your tablet with mineral water, fruit juice or other beverages.

Swallow the tablet whole. do not chew, crush or dissolve in the mouth.

For the next hour (60 minutes) after taking the tablet:

Do not lie down; if you do not stay upright (standing or sitting), some of the medicine could leak back into the esophagus.

Do not eat or drink anything (except tap water, if you need it). Do not take any other medicine.

After waiting 1 hour, you can have breakfast and the first drink of the day. Once you've eaten, you can, if you wish, lie down and take other medication you need.

Do not take this medicine at bedtime or before getting up in the morning,

It is important that you take Ibandronic acid every month (or every day) until directed by your doctor. This medicine is useful to treat osteoporosis only while you are taking it.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take ibandronic acid     

If a doctor prescribes another medicine, tell you are taking ibandronic acid.

Check with your doctor regularly developments of disorder that motivates the use of ibandronic acid. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with ibandronic acid at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with ibandronic acid, immediately consult your doctor.

If you take more than you should:

If you have taken by mistake too many tablets, drink a full glass of milk and talk to your doctor immediately. Do not induce vomiting nor lie down because it could injure the esophagus.

If you forget to take ibandronic acid

If you miss one or more doses of ibandronic acid, do not take more tablets to make up nor take another tablet later. Take the dose the next day when you wake up.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of ibandronic acid     

Like all medicines, ibandronic acid can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

Common side effects:

Heartburn (burning that rises from the stomach into the mouth), indigestion and diarrhea. Other possible side effects are rash and pain in muscles and joints.

These effects usually disappear after some time taking the drug. It is very likely that you can tolerate it. However, tell your doctor if these effects worsen or last long time.

Ibandronic acid can irritate the esophagus although you can avoid this by taking your dose according to the instructions. If you suffer symptoms such as severe pain in the chest, severe pain after swallowing food or drink, severe nausea or vomiting, tell immediately to your doctor.

This list does not include all adverse reactions associated with the use of ibandronic acid, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing ibandronic acid     

This page contains a list of brands of authorized pharmaceutical specialties of the active principle ibandronic acid in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

BONDRONAT 50 mg, 28 tablets
BONDRONAT 1 mg/ml, 6 ml injectable solution

Brazil:     

BONDRONAT 50 mg, 28-84 tablets
BONDRONAT 1 mg/ml, 6 ml injectable solution
BONVIVA 150 mg, 1-3 tablets
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONATO ACHÉ 150 mg, 1 tablet
IBANDRONATO BIOSINTÉTICA 150 mg, 1 tablet

Canada:     

N/A

France:     

ACIDE IBANDRONIQUE TEVA 150 mg, 1-3 tablets
BONDRONAT 1 mg/ml, 2 & 6 ml solution for perfusion
BONVIVA 150 mg, 1-3 tablets
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled

Germany:     

ASCENDRA 1 mg/ml, 3 ml solution for injection pre-filled
BONDRONAT 1 mg/ml, 2 & 6 ml solution for perfusion
BONDRONAT 50 mg, tablets
BONOSTE 150 mg, tablets
BONVIVA 150 mg, tablets
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONATE BLUEFISH 150 mg, tablets
IBANDRONATE BLUEFISH 50 mg, tablets
IBANDRONIC ACID ACCORD 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONIC ACID ACCORD 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE-1 A PHARMA 150 mg, tablets
IBANDRONSÄURE ABZ 150 mg, tablets
IBANDRONSÄURE ACTAVIS 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE ACTAVIS 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE ACTAVIS 150 mg, tablets
IBANDRONSÄURE AL 150 mg, tablets
IBANDRONSÄURE AL 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE AL 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE AL 50 mg, tablets
IBANDRONSÄURE BETA 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE CELL PHARM 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE CELL PHARM 50 mg, tablets
IBANDRONSÄURE CHEMI 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE HEXAL 150 mg, tablets
IBANDRONSÄURE HEXAL 1 mg/ml, 2, 4 & 6 ml solution for perfusion
IBANDRONSÄURE HEXAL 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE IBISQUS 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE IBISQUS 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE JUTA 150 mg, tablets
IBANDRONSÄURE NEOCORP 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE ONKOVIS 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE Q-PHARM 150 mg, tablets
IBANDRONSÄURE RATIOPHARM 150 mg, tablets
IBANDRONSÄURE RATIOPHARM 50 mg, tablets
IBANDRONSÄURE RATIOPHARM 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE RATIOPHARM 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE SANDOZ 50 mg, tablets
IBANDRONSÄURE STADA 150 mg, tablets
IBANDRONSÄURE STADA 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE STADA 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE SUN 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE-CT 1 mg/ml, 2 & 6 ml solution for perfusion
IBANDRONSÄURE-CT 1 mg/ml, 3 ml solution for injection pre-filled
IBANDRONSÄURE-CT 50 mg, tablets
RIBOBANDRON 1 mg/ml, 2 & 6 ml solution for perfusion

India:     

BANDRONE 1 mg/ml, 6 ml solution for perfusion
BANDRONE 150 mg, tablets
BANDRONE 50 mg, tablets
BONDRIA 1 mg/ml, 6 ml solution for perfusion
BONDRONAT 1 mg/ml, 6 ml solution for perfusion
BONDRONAT 50 mg, tablets
BONIMET 1 mg/ml, 6 ml solution for perfusion
BONVIVA 150 mg, tablets
EGYBAN 50 mg, tablets
EGYBAN 150 mg, tablets
EGYBAN 1 mg/ml, 6 ml solution for perfusion
IDROFOS 50 mg, tablets
IDROFOS 150 mg, tablets
IDROFOS 1 mg/ml, 3 ml solution for injection pre-filled
IDROFOS 1 mg/ml, 6 ml solution for perfusion
IRBEZ 150 mg, tablets
MONTHIBA 150 mg, tablets
VEBALONE 1 mg/ml, 3 ml solution for injection pre-filled
VEBALONE 150 mg, tablets

Italy:     

BONDRONAT 1 mg/ml, 6 ml solution for perfusion
BONDRONAT 50 mg, 28 tablets
BONVIVA 150 mg, 1 tablet
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
ACIDO IBANDRONICO CRINOS 150 mg, 1 tablet
ACIDO IBANDRONICO DOC GENERICI 150 mg, 1 tablet
ACIDO IBANDRONICO EG 150 mg, 1 tablet
ACIDO IBANDRONICO MYLAN 150 mg, 1 tablet
ACIDO IBANDRONICO SANDOZ 150 mg, 1 tablet
ACIDO IBANDRONICO TEVA 150 mg, 1 tablet
ACIDO IBANDRONICO ZENTIVA 150 mg, 1 tablet

Japan:     

BONVIVA 100 mg, tablet

Mexico:     

BONVIVA 150 mg, 1-3 tablets
BONVIVA 2.5 mg, 30 tablets

Pakistan:     

ADRONIL 150 mg, tablets
BIONIC 150 mg, tablets
BONETONE 150 mg, tablets
BONHEAL 150 mg, tablets
BONISH 150 mg, tablets
BONVIR 150 mg, tablets
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
BOONEST 150 mg, tablets
BREXELL PLUS 150 mg, tablets
IBAND 2.50 mg, tablets
FILBONE 150 mg, tablets
IBANDRO 150 mg, tablets
IBELAC 150 mg, tablets
IBNATE 150 mg, tablets
OSFIT 150 mg, tablets
ZOLTRANZ 150 mg, tablets

Spain:     

BONDENZA 150 mg, 1 tablet
BONDRONAT 50 mg, 28 tablets
BONDRONAT 1 mg/ml, 2 & 6 ml solution for perfusion
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
BONVIVA 150 mg, 1 tablet

Turkey:     

BONDRONAT 50 mg, 28-84 tablets
BONDRONAT 1 mg/ml, 6 ml solution for perfusion
BONMORE 1 mg/ml, 3 ml solution for injection pre-filled
BONVIVA ROCHE 150 MG 3 TABLET hkt - küb 101,15TLROCHE BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
FIXBONE 150 mg 3 SASE 101,15TLNEUTEC ILAC SAN. IBACUR 50 MG 28 SASE 196,5TLNEUTEC ILAC SAN. IBAMAX 150 MG 3 FILM TABLET 101,15TLULM ILAC IBANOS 150 MG 3 FILM TABLET 101,15TLGENERICA IBANOS 1 mg/ml, 3 ml solution for injection pre-filled
IBOFIX 150 MG 3 FILM KAPLI TABLET 101,15TLBILIM KEMIDAT 1 mg/ml, 6 ml solution for perfusion
KEMIVA 1 mg/ml, 3 ml solution for injection pre-filled
OSIBAN 1 mg/ml, 6 ml solution for perfusion
SEMPRIBAN 150 MG 3 TABLET 101,15TLZENTIVA SEMPRIBAN 1 mg/ml, 3 ml solution for injection pre-filled

United Kingdom:     

BONDRONAT 1 mg/ml, 2 & 6 mlconcentrate for solution for infusion
BONDRONAT 50 mg, 28 tablets
BONVIVA 150 mg, 1 & 3 tablets
BONVIVA 1 mg/ml, 3 ml solution for injection pre-filled
LASIBON 50 mg, 28 tablets
IIBANDRONIC ACID AAH PHARMA 50 mg, 28 tablets
IBANDRONIC ACID AAH PHARMA 150 mg, 1 & 3 tablets
IBANDRONIC ACID AAH PHARMA 1 mg/ml, 2 & 6 ml vial solution for infusion
IBANDRONIC ACID AAH PHARMA 1 mg/ml, 3 ml pre-filled syringes
IBANDRONIC ACID ACTAVIS 50 mg, 28 tablets
IBANDRONIC ACID ACTAVIS 150 mg, 1 & 3 tablets
IBANDRONIC ACID ACTAVIS 1 mg/ml, 3 ml pre-filled syringes
IBANDRONIC ACID ALLIANCE HEALTHCARE 50 mg, 28 tablets
IBANDRONIC ACID ALLIANCE HEALTHCARE 150 mg, 1 & 3 tablets
IBANDRONIC ACID ARROW 150 mg, 1 3 tablet
IBANDRONIC ACID GENERICS 150 mg, 1 & 3 tablets
IBANDRONIC ACID SANDOZ 50 mg, 28 tablets
IBANDRONIC ACID TEVA 50 mg, 28 tablets
IBANDRONIC ACID TEVA 150 mg, 1 & 3 tablets
IBANDRONIC ACID TEVA 1 mg/ml, 2 & 6 ml vial solution for infusion
IBANDRONIC ACID TEVA 1 mg/ml, 3 ml pre-filled syringes
IBANDRONIC ACID ZENTIVA 50 mg, 28 tablets
IBANDRONIC ACID ZENTIVA 150 mg, 1 & 3 tablets
QUODIXOR 150 mg, 1 tablet

U.S.A. and Puerto Rico:     

BONIVA 150 mg, 3 tablets
BONIVA 2.5 mg, 30 tablets
BONIVA 1 mg/ml, 3 ml pre-filled syringes

Page updated: December 11, 2010.